S. 3519 · 115th Congress
Making Objective Drug Evidence Revisions for New Labeling Act
- Stage
- In committee
- Sponsor
- Orrin Hatch
- Introduced
- 2018-09-27
- Latest action
- 2018-09-27 · Introduced in Senate
Subjects
Health
S. 3519 · 115th Congress